tiprankstipranks
Navidea Biopharmaceuticals (NAVB)
OTHER OTC:NAVB

Navidea (NAVB) Financial Statements

300 Followers

Navidea Financial Overview

Navidea's market cap is currently ―. The company's EPS TTM is $-0.054; its P/E ratio is -0.88; Navidea is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 610.00$ 7.52K
Gross Profit---$ -49.43K$ -126.92K
EBIT$ -2.16M$ -1.23M$ 1.87M$ -3.24M$ -4.95M
EBITDA$ -2.05M$ -1.09M$ 2.00M$ -3.29M$ -4.93M
Net Income Common Stockholders$ -2.26M$ 5.82M$ 3.37M$ -3.48M$ -7.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.86M$ 6.14M$ 33.80K$ 2.00M$ 4.60M
Total Assets$ 5.70M$ 8.22M$ 2.37M$ 4.37M$ 6.26M
Total Debt$ 10.70K$ 1.34M$ 354.37K$ 2.44M$ 1.82M
Net Debt$ -3.85M$ -4.81M$ 320.58K$ 439.76K$ -2.78M
Total Liabilities$ 8.68M$ 9.01M$ 11.92M$ 12.51M$ 10.93M
Stockholders Equity$ -3.27M$ -1.08M$ -9.84M$ -8.44M$ -4.96M
Cash Flow-
Free Cash Flow$ -9.52M$ 4.63M$ -1.76M$ -2.51M$ -1.94M
Operating Cash Flow$ -10.25M$ 4.69M$ -1.72M$ -2.43M$ -1.86M
Investing Cash Flow$ -524.66K$ -65.00K$ -39.41K$ -72.04K$ -78.93K
Financing Cash Flow$ -188.57K$ 1.48M$ -200.54K$ -99.76K$ 6.21M
Currency in USD

Navidea Earnings and Revenue History

Navidea Debt to Assets

Navidea Cash Flow

Navidea Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis